Abstract:Background Obesity has been widely reported to be associated with the disease progression of coronavirus disease 2019 (COVID-19); however, some studies have reported different findings. We conducted a systematic review and meta-analysis to investigate the association between obesity and poor outcomes in patients with COVID-19 pneumonia. Methods A systematic review and meta-analysis of studies from the PubMed, Embase, and Web of Science databases from 1 November 2019 to 24 May 2020 was performed. Study quality was assessed, and data extraction was conducted. The meta-analysis was carried out using fixed-effects and random-effects models to calculate odds ratios (ORs) of several poor outcomes in obese and non-obese COVID-19 patients. Results Twenty-two studies ( n = 12,591 patients) were included. Pooled analysis demonstrated that body mass index (BMI) was higher in severe/critical COVID-19 patients than in mild COVID-19 patients (MD 2.48 kg/m 2 , 95% CI [2.00 to 2.96 kg/m 2 ]). Additionally, obesity in COVID-19 patients was associated with poor outcomes (OR = 1.683, 95% CI [1.408–2.011]), which comprised severe COVID-19, ICU care, invasive mechanical ventilation use, and disease progression (OR = 4.17, 95% CI [2.32–7.48]; OR = 1.57, 95% CI [1.18–2.09]; OR = 2.13, 95% CI [1.10–4.14]; OR = 1.41, 95% CI [1.26–1.58], respectively). Obesity as a risk factor was greater in younger patients (OR 3.30 vs. 1.72). However, obesity did not increase the risk of hospital mortality (OR = 0.89, 95% CI [0.32–2.51]). Conclusions As a result of a potentially critical role of obesity in determining the severity of COVID-19, it is important to collect anthropometric information for COVID-19 patients, especially the younger group. However, obesity may not be associated with hospital mortality, and efforts to understand the impact of obesity on the mortality of COVID-19 patients should be a research priority in the future.

The interplay of aging, adipose tissue, and COVID-19: a potent alliance with implications for health

Obesity is Associated with Increased Severity of Disease in COVID-19 Pneumonia: a Systematic Review and Meta-Analysis

Aging mitochondria in the context of SARS-CoV-2: exploring interactions and implications

The Impact of Aging on Adipose Function and Adipokine Synthesis

Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort

Obesity Paradox in Aging: from Prevalence to Pathophysiology

Obesity and ageing: Two sides of the same coin

The interplay between obesity, immunosenescence, and insulin resistance

Finding a Link between Obesity and Senescence: A Systematic Review and Meta-Analysis

Obesity and aging: Molecular mechanisms and therapeutic approaches

Obesity May Accelerate the Aging Process

Are patients with severe obesity aging faster? Impact of severe obesity on different aspects of biological age

Influence of Adipokines on Metabolic Dysfunction and Aging

Considerations for Obesity, Vitamin D, and Physical Activity Amid the COVID‐19 Pandemic

Obesity population at risk of COVID-19 complications

Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives

Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19

Editorial: Obesity and Accelerated Aging

Ageing and Obesity Shared Patterns: From Molecular Pathogenesis to Epigenetics

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

Several areas of overlap between obesity and aging indicate obesity as a biomarker of accelerated aging of human B cell function and antibody responses